rosiglitazone has been researched along with Parkinson Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kieburtz, K | 1 |
| Chen, B; Desai, P; Ding, Y; He, B; Moorthy, G; Qiu, J; Shin, JH; Sun, Y; Tang, J; Wang, H; Wild, DJ | 1 |
| Martin, HL; Mounsey, RB; Mustafa, S; Sathe, K; Teismann, P | 1 |
| Carta, AR; Pisanu, A | 1 |
1 review(s) available for rosiglitazone and Parkinson Disease
| Article | Year |
|---|---|
Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?
Topics: Animals; Antiparkinson Agents; Encephalitis; Humans; Microglia; Parkinson Disease; Pioglitazone; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2013 |
3 other study(ies) available for rosiglitazone and Parkinson Disease
| Article | Year |
|---|---|
ADAGIO misses a beat?
Topics: Antiparkinson Agents; Disease Progression; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Research Design; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration | 2009 |
Mining relational paths in integrated biomedical data.
Topics: Algorithms; Computers; Data Collection; Data Mining; Databases, Factual; Humans; Hypoglycemic Agents; Ibuprofen; Medical Informatics; Models, Statistical; Myocardial Infarction; Parkinson Disease; Pioglitazone; Rosiglitazone; Software; Thiazolidinediones | 2011 |
Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease.
Topics: Anilides; Animals; Antioxidants; Cell Line, Tumor; Disease Models, Animal; Humans; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2012 |